Money · Lobbying reports · 119th Congress
H.R. 5526
21 saved lobbying reports name H.R. 5526.
21 reports
Confirmed from the official recordSenate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Lobbying Disclosure Act reports, LDA.gov. This copy was read October 7, 2026 at 6:24 PM Eastern.
Reports that name this bill
The amount is what the report gives for the whole quarter: everything the registrant did for that client, all issues together. A linked name opens that organization’s page on this site.
| Registrant | Client | Amount for the whole quarter | Quarter | Report |
|---|---|---|---|---|
| ASSOCIATION FOR CLINICAL ONCOLOGY | ASSOCIATION FOR CLINICAL ONCOLOGY | $480,000.00reported as expenses | April to June 2026 | Open the report |
| PRIME THERAPEUTICS | PRIME THERAPEUTICS | $100,000.00reported as expenses | April to June 2026 | Open the report |
| MEHLMAN CONSULTING, INC. | ASSOCIATION OF ACCESSIBLE MEDICINES | $60,000.00reported as income | April to June 2026 | Open the report |
| TIBER CREEK GROUP | AMGEN INC | $60,000.00reported as income | April to June 2026 | Open the report |
| THORN RUN PARTNERS | THE BIOSIMILARS FORUM | $100,000.00reported as income | April to June 2026 | Open the report |
| APOTEX CORP. | APOTEX CORP. | $730,000.00reported as expenses | April to June 2026 | Open the report |
| PFIZER INC. | PFIZER INC. | $1,880,000.00reported as expenses | April to June 2026 | Open the report |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | $260,000.00reported as expenses | April to June 2026 | Open the report |
| AVENUE SOLUTIONS | AMGEN, INC. | $50,000.00reported as income | April to June 2026 | Open the report |
| MEHLMAN CONSULTING, INC. | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | $90,000.00reported as income | April to June 2026 | Open the report |
| JOHNSON & JOHNSON SERVICES, INC. | JOHNSON & JOHNSON SERVICES INC | $1,440,000.00reported as expenses | April to June 2026 | Open the report |
| AMGEN, INC. | AMGEN INC | $2,440,000.00reported as expenses | April to June 2026 | Open the report |
| BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | $590,000.00reported as expenses | April to June 2026 | Open the report |
| FRESENIUS KABI USA LLC | FRESENIUS KABI USA LLC | $580,000.00reported as expenses | April to June 2026 | Open the report |
| KAISER FOUNDATION HEALTH PLAN INC. | KAISER FOUNDATION HEALTH PLAN INC | $530,000.00reported as expenses | April to June 2026 | Open the report |
| ASSOCIATION FOR ACCESSIBLE MEDICINES | ASSOCIATION FOR ACCESSIBLE MEDICINES | $870,000.00reported as expenses | April to June 2026 | Open the report |
| AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) | AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | $3,010,000.00reported as expenses | April to June 2026 | Open the report |
| AMERICAN COLLEGE OF RHEUMATOLOGY | AMERICAN COLLEGE OF RHEUMATOLOGY | $180,000.00reported as expenses | April to June 2026 | Open the report |
| COVINGTON & BURLING LLP | PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | $220,000.00reported as income | April to June 2026 | Open the report |
| NATIONAL TAXPAYERS UNION | NATIONAL TAXPAYERS UNION | $30,000.00reported as expenses | April to June 2026 | Open the report |
| WHITMER & WORRALL, LLC | CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) | $50,000.00reported as income | April to June 2026 | Open the report |